Share this article and save a life!
Healthcare AI just pulled in $100M+ this week. Here’s who got funded.
$77 million to Iterative Health (Series C)
$12 million to Lungpacer Medical (Convertible Note)
$3 million to TietAI (Seed)
$1 million to Depth Health (Seed)
These aren’t random bets.
Look at where the smart money is flowing:
🎯 Clinical AI that actually works
🎯 B2B software replacing broken systems
🎯 Hardware solving real patient problems
The standout? Iterative Health’s massive Series C.
They’re not building another chatbot. They’re tackling precision medicine with AI that helps gastroenterologists catch early stage diseases.
Remember when we hit $29.7 billion in global digital health funding last year?
We’re on track to beat it.
Q1 2026 alone saw $3 billion across 122 deals. That’s investor confidence despite economic headwinds.
But here’s what’s different this time:
Investors want clinical validation, not promises.
They want infrastructure, not apps.
They want ROI within 18 months.
Notice what’s NOT getting funded?
❌ Direct to consumer wellness apps
❌ Me-too telehealth platforms
❌ Solutions looking for problems
The message is clear: Build something hospitals will actually pay for.
Early stage startups like TietAI (Spain) and YStory (Japan) securing seed rounds proves global appetite for healthcare innovation remains strong.
Even convertible notes like Lungpacer’s $12M show creative funding structures are keeping innovation alive.
For healthcare executives watching this space:
These startups will be knocking on your door in 12 months.
Some will transform your operations.
Some will waste your time.
The difference? Look at their investors.
Boehringer Ingelheim backing Click Therapeutics tells you pharma sees digital therapeutics as real medicine.
CSS Insurance launching a CHF 400,000 grant pool tells you payers want preventive care innovation.
The average US digital health startup has raised $110.8 million.
That’s not experimentation money.
That’s transformation money.
Your vendors are getting acquired.
Your competitors are partnering with startups.
Your workforce expects modern tools.
The question isn’t whether to engage with healthcare startups.
It’s how fast you can evaluate them.
♻️ Repost if healthcare needs more smart capital, not just more capital
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
